Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin B Begg

Showing results (171-180 of 184) with videos related to

Pageof 19
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 4, 2025
Association of Inherited Genetic Variants with Multiple Primary MelanomaDavid C Gibbs, Brittany M Small, Isidora Autuori, et al.
Journal of the National Cancer Institute|February 10, 2016
Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma PathwaysDavid C Gibbs, Irene Orlow, Jennifer I Bramson, et al.
JAMA Dermatology|August 28, 2014
Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based studyNancy E Thomas, Anne Kricker, Weston T Waxweiler, et al.
The Journal of Investigative Dermatology|August 27, 2017
Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in MelanomaNancy E Thomas, Sharon N Edmiston, Peter A Kanetsky, et al.
Cancer Causes & Control : CCC|May 10, 2015
Proceedings of the second international molecular pathological epidemiology (MPE) meetingShuji Ogino, Peter T Campbell, Reiko Nishihara, et al.
Journal of the National Cancer Institute|January 5, 2006
Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendationsLois B Travis, Charles S Rabkin, Linda Morris Brown, et al.
JAMA Oncology|July 7, 2015
Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary MelanomaNancy E Thomas, Sharon N Edmiston, Audrey Alexander, et al.
Cancer Causes & Control : CCC|January 19, 2017
Proceedings of the third international molecular pathological epidemiology (MPE) meetingPeter T Campbell, Timothy R Rebbeck, Reiko Nishihara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2021
Development and Validation of a Breast Cancer Risk Prediction Model for Childhood Cancer Survivors Treated With Chest Radiation: A Report From the Childhood Cancer Survivor Study and the Dutch Hodgkin Late Effects and LATER CohortsChaya S Moskowitz, Cécile M Ronckers, Joanne F Chou, et al.
Pigment Cell & Melanoma Research|July 25, 2022
Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL studyLi Luo, Ronglai Shen, Arshi Arora, et al.
Pageof 19

Showing results (171-180 of 184) with videos related to

Sort By:
Pageof 19
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 4, 2025
Association of Inherited Genetic Variants with Multiple Primary MelanomaDavid C Gibbs, Brittany M Small, Isidora Autuori, et al.
Journal of the National Cancer Institute|February 10, 2016
Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma PathwaysDavid C Gibbs, Irene Orlow, Jennifer I Bramson, et al.
JAMA Dermatology|August 28, 2014
Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based studyNancy E Thomas, Anne Kricker, Weston T Waxweiler, et al.
The Journal of Investigative Dermatology|August 27, 2017
Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in MelanomaNancy E Thomas, Sharon N Edmiston, Peter A Kanetsky, et al.
Cancer Causes & Control : CCC|May 10, 2015
Proceedings of the second international molecular pathological epidemiology (MPE) meetingShuji Ogino, Peter T Campbell, Reiko Nishihara, et al.
Journal of the National Cancer Institute|January 5, 2006
Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendationsLois B Travis, Charles S Rabkin, Linda Morris Brown, et al.
JAMA Oncology|July 7, 2015
Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary MelanomaNancy E Thomas, Sharon N Edmiston, Audrey Alexander, et al.
Cancer Causes & Control : CCC|January 19, 2017
Proceedings of the third international molecular pathological epidemiology (MPE) meetingPeter T Campbell, Timothy R Rebbeck, Reiko Nishihara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2021
Development and Validation of a Breast Cancer Risk Prediction Model for Childhood Cancer Survivors Treated With Chest Radiation: A Report From the Childhood Cancer Survivor Study and the Dutch Hodgkin Late Effects and LATER CohortsChaya S Moskowitz, Cécile M Ronckers, Joanne F Chou, et al.
Pigment Cell & Melanoma Research|July 25, 2022
Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL studyLi Luo, Ronglai Shen, Arshi Arora, et al.
Pageof 19